Registration Dossier

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Waiver based on the physical state of the test compound.
General Physical Chemistry, SChering AG, Berlin. Study report NC54EY10 (APC 80/99), dated 1999-09-27.
The test ‘flash-point’ according to the EU-Guideline A.9 of Hydroxydrospirenone was not applicable, since Hydroxydrospirenone is a solid at room temperature.

Key value for chemical safety assessment

Additional information

Waiver, because an experimental study would be scientifically unjustified.